Arias Cesar A, Panesso Diana, Singh Kavindra V, Rice Louis B, Murray Barbara E
Department of Internal Medicine, Division of Infectious Diseases, University of Texas Medical School at Houston, Houston, TX 77030, USA.
Antimicrob Agents Chemother. 2009 Oct;53(10):4240-6. doi: 10.1128/AAC.00242-09. Epub 2009 Aug 10.
The hyl(Efm) gene (encoding a putative hyaluronidase) has been found almost exclusively in Enterococcus faecium clinical isolates, and recently, it was shown to be on a plasmid which increased the ability of E. faecium strains to colonize the gastrointestinal tract. In this work, the results of mating experiments between hyl(Efm)-containing strains of E. faecium belonging to clonal cluster 17 and isolated in the United States and Colombia indicated that the hyl(Efm) gene of these strains is also carried on large plasmids (>145 kb) which we showed transfer readily from clinical strains to E. faecium hosts. Cotransfer of resistance to vancomycin and high-level resistance (HLR) to aminoglycosides (gentamicin and streptomycin) and erythromycin was also observed. The vanA gene cluster and gentamicin resistance determinants were genetically linked to hyl(Efm), whereas erm(B) and ant(6)-I, conferring macrolide-lincosamide-streptogramin B resistance and HLR to streptomycin, respectively, were not. A hyl(Efm)-positive transconjugant resulting from a mating between a well-characterized endocarditis strain [TX0016 (DO)] and a derivative of a fecal strain of E. faecium from a healthy human volunteer (TX1330RF) exhibited increased virulence in a mouse peritonitis model. These results indicate that E. faecium strains use a strategy which involves the recruitment into the same genetic unit of antibiotic resistance genes and determinants that increase the ability to produce disease. Our findings indicate that the acquisition of the hyl(Efm) plasmids may explain, at least in part, the recent successful emergence of some E. faecium strains as nosocomial pathogens.
透明质酸酶(hyl(Efm))基因(编码一种假定的透明质酸酶)几乎仅在屎肠球菌临床分离株中发现,最近研究表明,该基因位于一个质粒上,该质粒增强了屎肠球菌菌株在胃肠道定殖的能力。在本研究中,对来自美国和哥伦比亚、属于克隆簇17的含hyl(Efm)基因的屎肠球菌菌株进行的接合实验结果表明,这些菌株的hyl(Efm)基因也携带在大于145 kb的大质粒上,我们发现该质粒很容易从临床菌株转移到屎肠球菌宿主。还观察到对万古霉素的抗性以及对氨基糖苷类(庆大霉素和链霉素)和红霉素的高水平抗性(HLR)的共转移。vanA基因簇和庆大霉素抗性决定簇与hyl(Efm)基因存在遗传连锁,而分别赋予大环内酯-林可酰胺-链阳霉素B抗性和对链霉素HLR的erm(B)和ant(6)-I基因则不存在这种连锁。由一株特征明确的心内膜炎菌株[TX0016 (DO)]与一名健康人类志愿者粪便中分离出的屎肠球菌菌株的衍生物(TX1330RF)进行接合产生的hyl(Efm)阳性转接合子,在小鼠腹膜炎模型中表现出更强的毒力。这些结果表明,屎肠球菌菌株采用了一种策略,即将抗生素抗性基因和增加致病能力的决定簇纳入同一遗传单位。我们的研究结果表明,hyl(Efm)质粒的获得可能至少部分解释了一些屎肠球菌菌株最近作为医院病原体成功出现的原因。